Literature DB >> 20693907

Contribution of anorexia to tissue wasting in cachexia.

Alessio Molfino1, Alessandro Laviano, Filippo Rossi Fanelli.   

Abstract

PURPOSE OF REVIEW: Anorexia is a severe debilitating symptom characterizing the clinical course of several chronic diseases. It negatively impacts on patient outcome by contributing to weight loss, lean body mass catabolism and adipose tissue wasting. Although disease-associated anorexia may stand alone as a clinically relevant symptom, it is now considered as a component of the cachexia syndrome. The present review discusses experimental and clinical data indicating that the pathogenic mechanisms of anorexia may also suggest a neural control of tissue wasting in cachexia. RECENT
FINDINGS: Consistent data show that selective melanocortin receptor antagonism modulates food intake and reduces wasting in experimental models of chronic disease. Consequently, ghrelin administration, whose prophagic effects are related to melanocortin antagonism, has been tested both in animal studies and human trials, with promising effects, although restoration of lean body mass has been not achieved. More interest is driven by the use of small molecules selectively antagonising hypothalamic melanocortin receptors.
SUMMARY: The 'brain-muscle axis' coordinated by the hypothalamus seems to mediate the onset of not only anorexia but also tissue wasting in cachexia, by centrally influencing energy homeostasis and the balance between anabolism and catabolism.

Entities:  

Mesh:

Year:  2010        PMID: 20693907     DOI: 10.1097/SPC.0b013e32833e4aa5

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  11 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

2.  Quality of life and its relation with nutritional status in patients with incurable cancer in palliative care.

Authors:  Livia Costa de Oliveira; Gabriela Travassos Abreu; Larissa Calixto Lima; Mariah Azevedo Aredes; Emanuelly Varea Maria Wiegert
Journal:  Support Care Cancer       Date:  2020-02-07       Impact factor: 3.603

Review 3.  Cancer cachexia: understanding the molecular basis.

Authors:  Josep M Argilés; Sílvia Busquets; Britta Stemmler; Francisco J López-Soriano
Journal:  Nat Rev Cancer       Date:  2014-10-09       Impact factor: 60.716

Review 4.  Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.

Authors:  Derek T Hall; Jennifer F Ma; Sergio Di Marco; Imed-Eddine Gallouzi
Journal:  Aging (Albany NY)       Date:  2011-08       Impact factor: 5.682

5.  Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways.

Authors:  Rafael Barreto; Giorgia Mandili; Frank A Witzmann; Francesco Novelli; Teresa A Zimmers; Andrea Bonetto
Journal:  Front Physiol       Date:  2016-10-19       Impact factor: 4.566

6.  Cancer anorexia: hypothalamic activity and its association with inflammation and appetite-regulating peptides in lung cancer.

Authors:  Alessio Molfino; Alessandro Iannace; Maria Chiara Colaiacomo; Alessio Farcomeni; Alessandra Emiliani; Gianfranco Gualdi; Alessandro Laviano; Filippo Rossi Fanelli
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-10-05       Impact factor: 12.910

Review 7.  A Pound of Flesh: What Cachexia Is and What It Is Not.

Authors:  Emanuele Berardi; Luca Madaro; Biliana Lozanoska-Ochser; Sergio Adamo; Lieven Thorrez; Marina Bouche; Dario Coletti
Journal:  Diagnostics (Basel)       Date:  2021-01-12

8.  Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia.

Authors:  Alessio Molfino; Raffaella Carletti; Giovanni Imbimbo; Maria Ida Amabile; Roberta Belli; Cira R T di Gioia; Elena Belloni; Francesco Spinelli; Veronica Rizzo; Carlo Catalano; Giuseppe Nigri; Maurizio Muscaritoli
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-22       Impact factor: 12.910

Review 9.  Current Screening Methods for the Risk or Presence of Malnutrition in Cancer Patients.

Authors:  Alessio Molfino; Giovanni Imbimbo; Alessandro Laviano
Journal:  Cancer Manag Res       Date:  2022-02-15       Impact factor: 3.989

Review 10.  Nonmuscle Tissues Contribution to Cancer Cachexia.

Authors:  Josep M Argilés; Britta Stemmler; Francisco J López-Soriano; Silvia Busquets
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.